David Morales, MD
Interventional Pain Medicine · Sun City West, AZNPI 1316248206
Payments from drug & device makers
Across 392 payments — averaging $35.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$6K
- Nevro Corp.$812
- Relievant Medsystems, Inc.$802
- Curonix LLC$582
- Nalu Medical, Inc.$574
- Abbott$543
- plus $5K from 45 others
What the payments were for
- Travel & lodging$3,80128%
- Food & beverage$9,64670%
- Education$3252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$2,809
- SPECTRA WAVEWRITER$1,453
- WaveWriter Alpha Prime 16$1,076
- Superion Indirect Decompression System$1,058
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$431
- Proclaim Family of SCS IPGs$283
- Omnia$280
- GENERAL PAIN MANAGEMENT$271
- Nalu Neurostimulation System$253
- Proclaim IPG$136
- Morphabond ER$136
- INTELLIS$133
- BELBUCA$127
- GENERAL VASCULAR INTERVENTION$117
- PAINTEQ$116
- mild Device Kit$112
- Stravix$108
- Grafix$108
- GrafixPL$108
How this compares
$13,772 in reported general payments places this provider in the 50th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 299 | $2,767 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 86 | $2,589 |
| Gabapentin | 158 | $2,584 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 80 | $2,003 |
| Pregabalin | 96 | $1,949 |
| Duloxetine Hcl | 90 | $1,277 |
| Baclofen | 79 | $957 |
| Oxycodone Hcl | 49 | $901 |
| Tizanidine Hcl | 77 | $716 |
| Tramadol Hcl | 67 | $361 |
| Diclofenac Sodium | 22 | $355 |
| Cyclobenzaprine Hcl | 20 | $260 |
| Morphine Sulfate ErMorphine Sulfate | 13 | $251 |
| Ropinirole Hcl | 13 | $126 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Sun City West
- Eric FeldmanSun City West$31K
- Matthew DoustPhoenix$12M
- Abram BurgherPhoenix$6.6M
- Lisa StearnsPhoenix$852K
- Paul LynchScottsdale$573K
- Bradley HoltTucson$508K
- Maaz IqbalMesa$273K
- Jack DiepLake Havasu City$234K
- Steven SiwekPhoenix$161K
- Matthew RansonMesa$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.